Fundraising Fox

Hancock Jaffe Laboratories

NASDAQ: NVNO

Irvine, US · Delaware corporation

Biotech

Founders & leadership

SM
Susan MontoyaExecutive
NJ
Norman JaffeNamed on SEC filing

Board

YZ
Yuri ZhiviloBoard director

Reported raises · per SEC filings

Form D private placements

$6.8M disclosed across 6 rounds · 2015–2020

▶$1.6MraisedAug 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Francis DuhayDirector
  • Robert Andrew BermanExecutive Officer, Director
  • Robert C. GrayDirector
  • Mark H. GlickmanExecutive Officer
  • Sanjay ShrivastavaDirector
  • Craig GlynnExecutive Officer
  • Matthew M. JenusaitisDirector
Offering amount
$1.6M
Amount sold
$1.6M
Minimum investment
$100K
Sales commissions
$102.8K
Placement agents
Ladenburg Thalmann & Co. Inc.,
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$650KraisedMar 2020 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert A. BermanExecutive Officer, Director
  • Robert C. GrayDirector
  • Sanjay ShrivastavaDirector
  • Francis Duhay, M.D.Director
  • Marc H. Glickman, M.D.Executive Officer
  • Robert RankinExecutive Officer
  • Matthew M. JenusaitisDirector
Offering amount
$890K
Amount sold
$650K
Sales commissions
$65K
Placement agents
Spartan Capital Securities LLC
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedMay 2019 · 105 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sanjay ShrivastavaDirector
  • Marc H. Glickman, M.D.Executive Officer
  • Yury ZhiviloExecutive Officer, Director
  • Robert A. BermanExecutive Officer, Director
  • Francis DuhayDirector
  • Robert RankinExecutive Officer
Offering amount
$2.7M
Amount sold
$2.7M
Sales commissions
$297.4K
Placement agents
NETWORK 1 FINANCIAL SECURITIES, INC.
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedJun 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benedict Broennimann, MDExecutive Officer
  • Gennady AlferenkoDirector
  • Marc Glickman, MDExecutive Officer, Director
  • Susan MontoyaExecutive Officer
  • Yury ZhiviloDirector
  • William AbbottExecutive Officer
  • Robert AndersonDirector
  • Robert DoyleDirector
Offering amount
$2M
Amount sold
$1M
Sales commissions
$100K
Placement agents
Alexander Capital, L.P.
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$194KraisedMar 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert DoyleDirector
  • Gennady AlferenkoDirector
  • Yury ZhiviloDirector
  • Benedict Broennimann, MDExecutive Officer
  • Susan MontoyaExecutive Officer
  • William AbbottExecutive Officer
  • Robert AndersonDirector
  • Marc Glickman, MDExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$194K
Sales commissions
$937.5K
Placement agents
Newbridge Securities Corporation
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$680KraisedDec 2015 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Norman JaffeExecutive Officer, Director
  • Susan MontoyaExecutive Officer, Director
  • Yuri ZhiviloDirector
Offering amount
$6.5M
Amount sold
$680K
Minimum investment
$50K
Sales commissions
$650K
Placement agents
Legend Securities, Inc.
First sale
Dec 2015
Incorporated
Corporation, New York
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Hancock Jaffe Gears Up for Pivotal Trial to Treat CVImddionline.com · Feb 2021Hancock Jaffe Completes $41 Million Public Offering - enVVeno Medical Corporationenvveno.com · Feb 2021Hancock Jaffe Laboratories Announces Pricing of Upsized $36 Million Offering | HJLI Stock Newsstocktitan.net · Feb 2021Here's Why Hancock Jaffe Laboratories (NASDAQ:HJLI) Must Use Its Cash Wiselyfinance.yahoo.com · Jun 2020

Frequently asked questions

How much funding has Hancock Jaffe Laboratories raised?
Hancock Jaffe Laboratories has disclosed $6.8M raised across 6 rounds.
Where is Hancock Jaffe Laboratories headquartered?
Hancock Jaffe Laboratories is headquartered in Irvine, US.